Novartis AG (LTS:0K9E)
$ 104.7 0 (0%) Market Cap: 209.81 Bil Enterprise Value: 227.95 Bil PE Ratio: 12.53 PB Ratio: 5.07 GF Score: 80/100

Meet Novartis AG Management Investor Event Transcript

Sep 22, 2022 / 06:00AM GMT
Release Date Price: $72.17 (-1.41%)
Samir Shah
Novartis AG - Global Head of IR

So thank you, everybody. Really appreciate you taking the time to come here to Basel. I know some of you have traveled from across the Atlantic, others from very difficult air routes from just across the channel. So thank you very much for coming.

It's our first in-person meeting for, I think, almost 3 years now, and we really welcome and all of our management really welcome the fact that we're together, you can ask the questions and we get your feedback. So that's great for us.

The way we're going to do the meeting of Novartis management is as we've always done it, except we also have a webcast as well. And we'll start with the agenda, and the first session is going to be with Vas going through our new strategy. We won't have too much time for Q&A in that first session simply because the group then meets with everybody in the 5 subsequent sessions, so you get the opportunity there and also for the people on the webcast, that will meet with the group section and with Vas.

Before we start, I just wanted to say the safe harbor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot